Traded Nov 19, 2025 · filed 3 days laterNot under a reported trading plan
A Roivant Sciences director sold $17.2M of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director received an award of 789 ROIV shares
Traded Oct 20, 2025 · Filed Oct 23, 2025
- 789
- Shares
Why it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Oct 20, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Oct 23, 2025
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001140361-25-038996
- Filed / recorded